Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Tax withholdingCommon Stock | 375 | $94.14 | $35,302.50 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 7 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,913.119 F5 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Disposition to issuerCommon Stock | 875 | $94.14 | $82,372.50 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,288.119 F4 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionCommon Stock | 2,000 | $41.16 | $82,320.00 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,163.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The SARs were settled in shares of common stock as per the terms of the award. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Disposition to issuerCommon Stock | 5,169 | $94.38 | $487,859.01 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,744.119 F1 · kind: The stock appreciation rights ("SARs") were settled in cash as per the terms of the award. For reporting purposes, however, the transaction is deemed to be a simultaneous acquisition and disposition of the underlying common stock and is reflected as such in this report. F2 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $94.27 to $94.48, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionCommon Stock | 996 | $58.22 | $57,987.12 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,163.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionCommon Stock | 2,360 | $61.91 | $146,107.60 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,167.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 20:01 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionCommon Stock | 1,813 | $63.11 | $114,418.43 |
DisclosureSEC source: 0001127602-19-008655 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,807.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:49 UTC |
Moriarty Sean ThomasVP & GM Polymers
|
Exercise / conversionPerformance Shares · Derivative | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007750 · form4.xml · derivative · entry 6 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,368 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:49 UTC |
Moriarty Sean ThomasVP & GM Polymers
|
GrantPerformance Shares · Derivative | 1,950 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007750 · form4.xml · derivative · entry 5 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,950 Underlying: Common Stock · 1,950 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · price: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:49 UTC |
Moriarty Sean ThomasVP & GM Polymers
|
GrantStock Appreciation Right · Derivative | 7,593 | $0.00 Strike: $9,229.00 | $0.00 |
DisclosureSEC source: 0001127602-19-007750 · form4.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,593 Underlying: Common Stock · 7,593 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:49 UTC |
Moriarty Sean ThomasVP & GM Polymers
|
GrantStock Option (Right to Buy) · Derivative | 2,531 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007750 · form4.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,531 Underlying: Common Stock · 2,531 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:49 UTC |
Moriarty Sean ThomasVP & GM Polymers
|
GrantCommon Stock | 81.636 | $92.29 | $7,534.19 |
DisclosureSEC source: 0001127602-19-007750 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Polymers 10b5-1 filing: Not disclosed Ownership: Indirect · By ESOP II Trust Disclosed balance after: 3,744.367 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:49 UTC |
Moriarty Sean ThomasVP & GM Polymers
|
Exercise / conversionCommon Stock | 2,529 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007750 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Polymers 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,796.5426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
GrantShare Units · Derivative | 2,263.195 | $92.57 | $209,503.96 |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · derivative · entry 7 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,209.72 Underlying: Common Stock · 2,263.195 shares Expires not disclosed F5 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · derivative.exercise_date: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F6 · derivative.expiration_date: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
Exercise / conversionPerformance Shares · Derivative | 3,649 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · derivative · entry 6 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
GrantPerformance Shares · Derivative | 2,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · derivative · entry 5 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,601 Underlying: Common Stock · 2,601 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
GrantStock Appreciation Right · Derivative | 10,124 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · derivative · entry 4 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,124 Underlying: Common Stock · 10,124 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
GrantStock Option (Right to Buy) · Derivative | 3,375 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · derivative · entry 3 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 3,375 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
GrantCommon Stock | 81.636 | $92.29 | $7,534.19 |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · nonDerivative · entry 2 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 6,429.332 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:51 UTC |
Mergner Arthur WVP, Supply Chain
|
Exercise / conversionCommon Stock | 6,744 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007752 · form4.xml · nonDerivative · entry 1 Mergner Arthur W · CIK 0001603410 · VP, Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,153.661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionPerformance Shares · Derivative | 3,649 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantPerformance Shares · Derivative | 2,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,601 Underlying: Common Stock · 2,601 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantStock Appreciation Right · Derivative | 10,124 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,124 Underlying: Common Stock · 10,124 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantStock Option (Right to Buy) · Derivative | 3,375 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 3,375 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC |
Behrens Scott R.VP/GM Surfactants
|
GrantCommon Stock | 81.636 | $92.29 | $7,534.19 |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,592.195 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:50 UTC |
Behrens Scott R.VP/GM Surfactants
|
Exercise / conversionCommon Stock | 6,744 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007751 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,994.119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:47 UTC |
STEPAN F QUINN JRDirector · Chairman, President & CEO
|
Exercise / conversionPerformance Shares · Derivative | 15,507 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007748 · form4.xml · derivative · entry 12 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,507 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F6 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F6 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:47 UTC |
STEPAN F QUINN JRDirector · Chairman, President & CEO
|
GrantPerformance Shares · Derivative | 10,836 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007748 · form4.xml · derivative · entry 11 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,836 Underlying: Common Stock · 10,836 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F5 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F5 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F5 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:47 UTC |
STEPAN F QUINN JRDirector · Chairman, President & CEO
|
GrantStock Appreciation Right · Derivative | 28,122 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007748 · form4.xml · derivative · entry 10 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,122 Underlying: Common Stock · 28,122 shares Expires 2029-02-19 F4 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:47 UTC |
STEPAN F QUINN JRDirector · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 28,122 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007748 · form4.xml · derivative · entry 9 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,122 Underlying: Common Stock · 28,122 shares Expires 2029-02-19 F4 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:47 UTC |
STEPAN F QUINN JRDirector · Chairman, President & CEO
|
GrantCommon Stock | 81.636 | $92.29 | $7,534.19 |
DisclosureSEC source: 0001127602-19-007748 · form4.xml · nonDerivative · entry 2 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 11,274.429 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:47 UTC |
STEPAN F QUINN JRDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 28,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007748 · form4.xml · nonDerivative · entry 1 STEPAN F QUINN JR · CIK 0001229289 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,099.935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:48 UTC |
Stefaniak DebraVP, Business Enablement
|
Exercise / conversionPerformance Shares · Derivative | 1,824 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007749 · form4.xml · derivative · entry 6 Stefaniak Debra · CIK 0001656944 · VP, Business Enablement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,824 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:48 UTC |
Stefaniak DebraVP, Business Enablement
|
GrantPerformance Shares · Derivative | 1,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007749 · form4.xml · derivative · entry 5 Stefaniak Debra · CIK 0001656944 · VP, Business Enablement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:48 UTC |
Stefaniak DebraVP, Business Enablement
|
GrantStock Appreciation Right · Derivative | 5,062 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007749 · form4.xml · derivative · entry 4 Stefaniak Debra · CIK 0001656944 · VP, Business Enablement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,062 Underlying: Common Stock · 5,062 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:48 UTC |
Stefaniak DebraVP, Business Enablement
|
GrantStock Option (Right to Buy) · Derivative | 1,687 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007749 · form4.xml · derivative · entry 3 Stefaniak Debra · CIK 0001656944 · VP, Business Enablement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,687 Underlying: Common Stock · 1,687 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:48 UTC |
Stefaniak DebraVP, Business Enablement
|
GrantCommon Stock | 81.636 | $92.29 | $7,534.19 |
DisclosureSEC source: 0001127602-19-007749 · form4.xml · nonDerivative · entry 2 Stefaniak Debra · CIK 0001656944 · VP, Business Enablement 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 2,555.314 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:48 UTC |
Stefaniak DebraVP, Business Enablement
|
Exercise / conversionCommon Stock | 3,371 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007749 · form4.xml · nonDerivative · entry 1 Stefaniak Debra · CIK 0001656944 · VP, Business Enablement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,170.196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:46 UTC |
Catlett Janet AnneVP, CHRO
|
GrantShare Units · Derivative | 756.185 | $92.57 | $70,000.05 |
DisclosureSEC source: 0001127602-19-007745 · form4.xml · derivative · entry 5 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756.185 Underlying: Common Stock · 756.185 shares Expires not disclosed F3 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F4 · derivative.exercise_date: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.expiration_date: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:46 UTC |
Catlett Janet AnneVP, CHRO
|
GrantPerformance Shares · Derivative | 1,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007745 · form4.xml · derivative · entry 4 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F2 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:46 UTC |
Catlett Janet AnneVP, CHRO
|
GrantStock Appreciation Right · Derivative | 5,062 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007745 · form4.xml · derivative · entry 3 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,062 Underlying: Common Stock · 5,062 shares Expires 2029-02-19 F1 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:46 UTC |
Catlett Janet AnneVP, CHRO
|
GrantStock Option (Right to Buy) · Derivative | 1,687 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007745 · form4.xml · derivative · entry 2 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,687 Underlying: Common Stock · 1,687 shares Expires 2029-02-19 F1 · derivative.exercise_date: Vests ratably over three years beginning on date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:46 UTC |
Catlett Janet AnneVP, CHRO
|
GrantCommon Stock | 36.566 | $92.29 | $3,374.68 |
DisclosureSEC source: 0001127602-19-007745 · form4.xml · nonDerivative · entry 1 Catlett Janet Anne · CIK 0001747846 · VP, CHRO 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 36.566 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:45 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantPerformance Shares · Derivative | 2,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007743 · form4.xml · derivative · entry 4 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,601 Underlying: Common Stock · 2,601 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F2 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F2 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F2 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:45 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantStock Appreciation Right · Derivative | 10,124 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007743 · form4.xml · derivative · entry 3 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,124 Underlying: Common Stock · 10,124 shares Expires 2029-02-19 F1 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:45 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 3,375 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007743 · form4.xml · derivative · entry 2 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 3,375 shares Expires 2029-02-19 F1 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:45 UTC |
Rojo LuisVP & Chief Financial Officer
|
GrantCommon Stock | 74.777 | $92.29 | $6,901.17 |
DisclosureSEC source: 0001127602-19-007743 · form4.xml · nonDerivative · entry 1 Rojo Luis · CIK 0001738439 · VP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 74.777 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:44 UTC |
PACHOLEC FRANKVice President, Strategy
|
Exercise / conversionPerformance Shares · Derivative | 1,824 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007740 · form4.xml · derivative · entry 7 PACHOLEC FRANK · CIK 0001229293 · Vice President, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,824 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2018. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:44 UTC |
PACHOLEC FRANKVice President, Strategy
|
GrantPerformance Shares · Derivative | 1,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007740 · form4.xml · derivative · entry 6 PACHOLEC FRANK · CIK 0001229293 · Vice President, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2021. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 21:44 UTC |
PACHOLEC FRANKVice President, Strategy
|
GrantStock Appreciation Right · Derivative | 5,062 | $0.00 Strike: $92.29 | $0.00 |
DisclosureSEC source: 0001127602-19-007740 · form4.xml · derivative · entry 5 PACHOLEC FRANK · CIK 0001229293 · Vice President, Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,062 Underlying: Common Stock · 5,062 shares Expires 2029-02-19 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.